FG
GSK icon

Fairman Group’s GSK GSK Stock Holding History

Fairman Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Hold
20
– – ﹤0.01% 304
2026
Q1 		$1.11K Hold
20
– – ﹤0.01% 294
2025
Q4 		$989 Hold
20
– – ﹤0.01% 302
2025
Q3 		$872 Hold
20
– – ﹤0.01% 245
2025
Q2 		$777 Hold
20
– – ﹤0.01% 228
2025
Q1 		$3.42K Sell
20
-80
-80% -$2.93K ﹤0.01% 184
2024
Q4 		$3.42K Hold
100
– – ﹤0.01% 201
2024
Q3 		$4.13K Hold
100
– – ﹤0.01% 215
2024
Q2 		$3.89K Hold
100
– – ﹤0.01% 215
2024
Q1 		$4.33K Hold
100
– – ﹤0.01% 203
2023
Q4 		$3.74K Buy
+100
New +$3.59K ﹤0.01% 212

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fairman Group's GSK Position: Q2 2026 in Review

Fairman Group held its GSK (GSK) position steady in Q2 2026 at 20 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Fairman Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.33K in Q1 2024. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Fairman Group held 20 shares of GSK worth $1.06K as of Q2 2026.
  • Fairman Group left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #304 holding.
  • Fairman Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's GSK position peaked at $4.33K in Q1 2024.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.